Wrestling the Octopus (IBD)
Wrestling the Octopus (IBD)
Podcast Description
Two long-term IBD patients, Rachel and Nigel, share their experiences and perspectives on living with inflammatory bowel disease (Crohn's disease and ulcerative colitis).
Podcast Insights
Content Themes
Explores themes of medication management, lifestyle adjustments, and emotional support for IBD patients, featuring episodes such as Medication Decisions: To Start or Stop and Navigating Remission, with discussions centered around patient experiences and healthcare interactions.
Two long-term IBD patients, Rachel and Nigel, share their experiences and perspectives on living with inflammatory bowel disease (Crohn’s disease and ulcerative colitis).
Welcome to Episode 2 in our 8-part podcast series on living with inflammatory bowel disease.
We’re talking how we take medication in this episode: IV infusions, self-injectables (sub-cut) and oral tablets.
What are the pros and cons of each method and how do anxiety, disease state and other factors influence patient decisions on how to receive medication?
And why might oral medication not necessarily be the choice of patients even though it’s undoubtedly convenient?
We also mention a recent study on whether to disclose Crohn’s disease at work. Here is the link if you’d like to read more on that: https://www.mdpi.com/2624-5647/7/1/18
We hope you enjoy this podcast… please do let us know your thoughts!
Follow Rachel at @bottomlineibd
Follow Nigel at @crohnoid
Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.